Robin L. Carmichael, President and Chief Executive Officer
Robin L Carmichael was appointed our President and Chief Executive Officer in July 2017. Prior to this role, she was our President from February 2015 and had served as our Chief Operating Officer since January 2011. She has served as a member of our board of directors since February 2013 and was appointed Chairperson of the Board in September 2024. Ms. Carmichael joined Helix BioMedix in October 2007 as our vice president of marketing and business development. Prior to joining us, she served as chief operating officer of DERMAdoctor, Inc., a dermoceutical company. She was vice president of marketing with ProCyte Corporation from 1998 to 2005 and later at PhotoMedex, Inc. following its acquisition of ProCyte in 2005. During her tenure at ProCyte, she gained drug development and clinical trial experience, developed and launched seven major product lines, and established international distribution. She has been a member of the board of directors of IGY Lifesciences since July 2022. Ms. Carmichael has over 25 years of senior management positions in the life science and medical device companies, including Baxter Healthcare. She holds a Bachelor of Science in Nursing from Seattle University and attended the UCLA Anderson Graduate School of Executive Management.
Ms. Carmichael has significant senior-level management experience in the biotechnology and consumer products industries and brings to our board valuable knowledge of the strategic, marketing and operational aspects of the biotechnology and consumer products industries. Her experience makes her a strong contributor to our board.